Spencer S. Ericksen, Ph.D. - Publications

2005 West Virginia University, Morgantown, WV, United States 
Pharmaceutical Chemistry, Biochemistry

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Sukumar S, Zhu X, Ericksen SS, Mitchell JC. DBSI Server: DNA Binding Site Identifier. Bioinformatics (Oxford, England). PMID 27259543 DOI: 10.1093/Bioinformatics/Btw315  0.349
2013 Zhu X, Ericksen SS, Mitchell JC. DBSI: DNA-binding site identifier. Nucleic Acids Research. 41: e160. PMID 23873960 DOI: 10.1093/Nar/Gkt617  0.305
2012 Huang Q, Deshmukh RS, Ericksen SS, Tu Y, Szklarz GD. Preferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 2324-31. PMID 22949628 DOI: 10.1124/Dmd.112.047308  0.462
2012 Ericksen SS, Cummings DF, Teer ME, Amdani S, Schetz JA. Ring substituents on substituted benzamide ligands indirectly mediate interactions with position 7.39 of transmembrane helix 7 of the D4 dopamine receptor. The Journal of Pharmacology and Experimental Therapeutics. 342: 472-85. PMID 22588261 DOI: 10.1124/Jpet.112.193979  0.355
2010 Cummings DF, Ericksen SS, Goetz A, Schetz JA. Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548. The Journal of Pharmacology and Experimental Therapeutics. 333: 682-95. PMID 20215412 DOI: 10.1124/Jpet.109.164962  0.328
2009 Ericksen SS, Cummings DF, Weinstein H, Schetz JA. Ligand selectivity of D2 dopamine receptors is modulated by changes in local dynamics produced by sodium binding. The Journal of Pharmacology and Experimental Therapeutics. 328: 40-54. PMID 18849360 DOI: 10.1124/Jpet.108.141531  0.343
2007 Sancar F, Ericksen SS, Kucken AM, Teissére JA, Czajkowski C. Structural determinants for high-affinity zolpidem binding to GABA-A receptors. Molecular Pharmacology. 71: 38-46. PMID 17012619 DOI: 10.1124/Mol.106.029595  0.357
2005 Ericksen SS, Szklarz GD. Regiospecificity of human cytochrome P450 1A1-mediated oxidations: the role of steric effects. Journal of Biomolecular Structure & Dynamics. 23: 243-56. PMID 16218752 DOI: 10.1080/07391102.2005.10507063  0.74
2004 Schwarz D, Kisselev P, Ericksen SS, Szklarz GD, Chernogolov A, Honeck H, Schunck WH, Roots I. Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid. Biochemical Pharmacology. 67: 1445-57. PMID 15041462 DOI: 10.1016/J.Bcp.2003.12.023  0.716
2004 Liu J, Ericksen SS, Sivaneri M, Besspiata D, Fisher CW, Szklarz GD. The effect of reciprocal active site mutations in human cytochromes P450 1A1 and 1A2 on alkoxyresorufin metabolism. Archives of Biochemistry and Biophysics. 424: 33-43. PMID 15019834 DOI: 10.1016/J.Abb.2003.12.040  0.738
2003 Liu J, Ericksen SS, Besspiata D, Fisher CW, Szklarz GD. Characterization of substrate binding to cytochrome P450 1A1 using molecular modeling and kinetic analyses: case of residue 382. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 31: 412-20. PMID 12642467 DOI: 10.1124/Dmd.31.4.412  0.758
Show low-probability matches.